Silo Pharma (SILO) Competitors

$0.45 -0.01 (-2.17%)

Closing price 04:00 PM Eastern

Extended Trading

$0.46 +0.01 (+1.55%)

As of 05:59 PM Eastern

SILO vs. PMNT, EVKG, ONON, AS, and LULU

Should you be buying Silo Pharma stock or one of its competitors? The main competitors of Silo Pharma include Perfect Moment (PMNT), Ever-Glory International Group (EVKG), ON (ONON), Amer Sports (AS), and lululemon athletica (LULU). These companies are all part of the "apparel" industry.

How does Silo Pharma compare to Perfect Moment?

Perfect Moment (NASDAQ:PMNT) and Silo Pharma (NASDAQ:SILO) are both small-cap apparel companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings.

: Perfect Moment has a beta of -1.89, meaning that its stock price is 289% less volatile than the S&P 500. Comparatively, Silo Pharma has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500.
: In the previous week, Silo Pharma had 3 more articles in the media than Perfect Moment. MarketBeat recorded 4 mentions for Silo Pharma and 1 mentions for Perfect Moment. Perfect Moment's average media sentiment score of 0.00 equaled Silo Pharma'saverage media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Perfect Moment
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Silo Pharma
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 23.0% of Perfect Moment shares are held by institutional investors. Comparatively, 5.6% of Silo Pharma shares are held by institutional investors. 22.2% of Perfect Moment shares are held by insiders. Comparatively, 2.2% of Silo Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
: Silo Pharma has lower revenue, but higher earnings than Perfect Moment. Silo Pharma is trading at a lower price-to-earnings ratio than Perfect Moment, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Perfect Moment $22.93M 0.49 -$8.72M -$0.72 N/A
Silo Pharma $70K 104.83 -$4.23M -$0.54 N/A
: Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -5,870.83%. Silo Pharma's return on equity of -83.53% beat Perfect Moment's return on equity.
Company Net Margins Return on Equity Return on Assets
Perfect Moment -67.38% -513.83% -119.38%
Silo Pharma -5,870.83% -83.53% -63.70%
: Perfect Moment currently has a consensus target price of $1.50, suggesting a potential upside of 523.96%. Given Perfect Moment's stronger consensus rating and higher probable upside, equities analysts clearly believe Perfect Moment is more favorable than Silo Pharma.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Perfect Moment
0 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
Silo Pharma
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Perfect Moment	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Silo Pharma	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perfect Moment	$22.93M	0.49	-$8.72M	-$0.72	N/A
Silo Pharma	$70K	104.83	-$4.23M	-$0.54	N/A

Company	Net Margins	Return on Equity	Return on Assets
Perfect Moment	-67.38%	-513.83%	-119.38%
Silo Pharma	-5,870.83%	-83.53%	-63.70%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perfect Moment	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Perfect Moment beats Silo Pharma on 8 of the 15 factors compared between the two stocks.

How does Silo Pharma compare to Ever-Glory International Group?

Ever-Glory International Group (NASDAQ:EVKG) and Silo Pharma (NASDAQ:SILO) are both small-cap apparel companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings.

: Ever-Glory International Group has a beta of 5.31, meaning that its stock price is 431% more volatile than the S&P 500. Comparatively, Silo Pharma has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ever-Glory International Group
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Silo Pharma
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: In the previous week, Silo Pharma had 4 more articles in the media than Ever-Glory International Group. MarketBeat recorded 4 mentions for Silo Pharma and 0 mentions for Ever-Glory International Group. Ever-Glory International Group's average media sentiment score of 0.00 equaled Silo Pharma'saverage media sentiment score.
Company Overall Sentiment
Ever-Glory International Group Neutral
Silo Pharma Neutral
: Ever-Glory International Group has higher earnings, but lower revenue than Silo Pharma.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ever-Glory International Group N/A N/A N/A N/A N/A
Silo Pharma $70K 104.83 -$4.23M -$0.54 N/A
: 5.6% of Silo Pharma shares are held by institutional investors. 35.5% of Ever-Glory International Group shares are held by insiders. Comparatively, 2.2% of Silo Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
: Ever-Glory International Group has a net margin of 0.00% compared to Silo Pharma's net margin of -5,870.83%. Ever-Glory International Group's return on equity of 0.00% beat Silo Pharma's return on equity.
Company Net Margins Return on Equity Return on Assets
Ever-Glory International Group N/A N/A N/A
Silo Pharma -5,870.83% -83.53% -63.70%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ever-Glory International Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Overall Sentiment
Ever-Glory International Group	Neutral
Silo Pharma	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A
Silo Pharma	$70K	104.83	-$4.23M	-$0.54	N/A

Company	Net Margins	Return on Equity	Return on Assets
Ever-Glory International Group	N/A	N/A	N/A
Silo Pharma	-5,870.83%	-83.53%	-63.70%

Summary

Ever-Glory International Group beats Silo Pharma on 6 of the 10 factors compared between the two stocks.

How does Silo Pharma compare to ON?

Silo Pharma (NASDAQ:SILO) and ON (NYSE:ONON) are both apparel companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

: ON has a net margin of 6.59% compared to Silo Pharma's net margin of -5,870.83%. ON's return on equity of 13.25% beat Silo Pharma's return on equity.
Company Net Margins Return on Equity Return on Assets
Silo Pharma -5,870.83% -83.53% -63.70%
ON 6.59% 13.25% 7.56%
: 5.6% of Silo Pharma shares are held by institutional investors. Comparatively, 36.4% of ON shares are held by institutional investors. 2.2% of Silo Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
: ON has a consensus target price of $58.40, suggesting a potential upside of 68.95%. Given ON's stronger consensus rating and higher probable upside, analysts plainly believe ON is more favorable than Silo Pharma.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Silo Pharma
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
ON
2 Sell rating(s)

3 Hold rating(s)

17 Buy rating(s)

2 Strong Buy rating(s)
2.79
: In the previous week, ON had 9 more articles in the media than Silo Pharma. MarketBeat recorded 13 mentions for ON and 4 mentions for Silo Pharma. ON's average media sentiment score of 0.78 beat Silo Pharma's score of 0.00 indicating that ON is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Silo Pharma
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ON
6 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: ON has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than ON, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Silo Pharma $70K 104.83 -$4.23M -$0.54 N/A
ON $3.64B 6.06 $245.87M $0.72 48.01
: Silo Pharma has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, ON has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Silo Pharma	-5,870.83%	-83.53%	-63.70%
ON	6.59%	13.25%	7.56%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
ON	2 Sell rating(s)	3 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.79

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Silo Pharma	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ON	6 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Silo Pharma	$70K	104.83	-$4.23M	-$0.54	N/A
ON	$3.64B	6.06	$245.87M	$0.72	48.01

Summary

ON beats Silo Pharma on 15 of the 17 factors compared between the two stocks.

How does Silo Pharma compare to Amer Sports?

Silo Pharma (NASDAQ:SILO) and Amer Sports (NYSE:AS) are both apparel companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

: Amer Sports has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than Amer Sports, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Silo Pharma $70K 104.83 -$4.23M -$0.54 N/A
Amer Sports $6.57B 2.94 $427.40M $0.75 46.40
: Silo Pharma has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500. Comparatively, Amer Sports has a beta of 2.17, meaning that its stock price is 117% more volatile than the S&P 500.
: In the previous week, Silo Pharma had 3 more articles in the media than Amer Sports. MarketBeat recorded 4 mentions for Silo Pharma and 1 mentions for Amer Sports. Amer Sports' average media sentiment score of 0.93 beat Silo Pharma's score of 0.00 indicating that Amer Sports is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Silo Pharma
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Amer Sports
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: Amer Sports has a consensus target price of $47.12, suggesting a potential upside of 35.42%. Given Amer Sports' stronger consensus rating and higher possible upside, analysts plainly believe Amer Sports is more favorable than Silo Pharma.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Silo Pharma
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Amer Sports
0 Sell rating(s)

2 Hold rating(s)

15 Buy rating(s)

2 Strong Buy rating(s)
3.00
: 5.6% of Silo Pharma shares are held by institutional investors. Comparatively, 40.3% of Amer Sports shares are held by institutional investors. 2.2% of Silo Pharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: Amer Sports has a net margin of 6.51% compared to Silo Pharma's net margin of -5,870.83%. Amer Sports' return on equity of 9.74% beat Silo Pharma's return on equity.
Company Net Margins Return on Equity Return on Assets
Silo Pharma -5,870.83% -83.53% -63.70%
Amer Sports 6.51% 9.74% 5.80%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Silo Pharma	$70K	104.83	-$4.23M	-$0.54	N/A
Amer Sports	$6.57B	2.94	$427.40M	$0.75	46.40

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Silo Pharma	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Amer Sports	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Amer Sports	0 Sell rating(s)	2 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.00

Company	Net Margins	Return on Equity	Return on Assets
Silo Pharma	-5,870.83%	-83.53%	-63.70%
Amer Sports	6.51%	9.74%	5.80%

Summary

Amer Sports beats Silo Pharma on 14 of the 17 factors compared between the two stocks.

How does Silo Pharma compare to lululemon athletica?

lululemon athletica (NASDAQ:LULU) and Silo Pharma (NASDAQ:SILO) are both apparel companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

: In the previous week, lululemon athletica had 32 more articles in the media than Silo Pharma. MarketBeat recorded 36 mentions for lululemon athletica and 4 mentions for Silo Pharma. lululemon athletica's average media sentiment score of 0.27 beat Silo Pharma's score of 0.00 indicating that lululemon athletica is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
lululemon athletica
11 Very Positive mention(s)
4 Positive mention(s)
10 Neutral mention(s)
8 Negative mention(s)
3 Very Negative mention(s)
Neutral
Silo Pharma
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 85.2% of lululemon athletica shares are owned by institutional investors. Comparatively, 5.6% of Silo Pharma shares are owned by institutional investors. 0.5% of lululemon athletica shares are owned by company insiders. Comparatively, 2.2% of Silo Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
: lululemon athletica currently has a consensus price target of $205.34, indicating a potential upside of 57.70%. Given lululemon athletica's stronger consensus rating and higher possible upside, research analysts clearly believe lululemon athletica is more favorable than Silo Pharma.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
lululemon athletica
2 Sell rating(s)
28 Hold rating(s)

2 Buy rating(s)

1 Strong Buy rating(s)
2.06
Silo Pharma
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: lululemon athletica has a net margin of 14.22% compared to Silo Pharma's net margin of -5,870.83%. lululemon athletica's return on equity of 34.82% beat Silo Pharma's return on equity.
Company Net Margins Return on Equity Return on Assets
lululemon athletica 14.22% 34.82% 20.14%
Silo Pharma -5,870.83% -83.53% -63.70%
: lululemon athletica has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Silo Pharma has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500.
: lululemon athletica has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than lululemon athletica, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
lululemon athletica $11.10B 1.42 $1.58B $13.30 9.79
Silo Pharma $70K 104.83 -$4.23M -$0.54 N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
lululemon athletica	11 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	8 Negative mention(s)	3 Very Negative mention(s)	Neutral
Silo Pharma	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
lululemon athletica	2 Sell rating(s)	28 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.06
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
lululemon athletica	14.22%	34.82%	20.14%
Silo Pharma	-5,870.83%	-83.53%	-63.70%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
lululemon athletica	$11.10B	1.42	$1.58B	$13.30	9.79
Silo Pharma	$70K	104.83	-$4.23M	-$0.54	N/A

Summary

lululemon athletica beats Silo Pharma on 15 of the 17 factors compared between the two stocks.

Get Silo Pharma News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SILO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SILO vs. The Competition

Export

Metric	Silo Pharma	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$7.34M	$3.39B	$6.25B	$11.87B
Dividend Yield	N/A	2.20%	2.73%	5.21%
P/E Ratio	-0.84	38.85	29.04	28.47
Price / Sales	104.83	155.51	476.61	60.92
Price / Cash	N/A	57.88	27.62	36.52
Price / Book	0.96	7.03	9.67	6.67
Net Income	-$4.23M	$23.62M	$3.55B	$332.53M
7 Day Performance	1.62%	3.68%	1.70%	2.01%
1 Month Performance	30.50%	7.16%	5.62%	9.19%
1 Year Performance	-39.30%	67.05%	34.41%	39.59%

Silo Pharma Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SILO Silo Pharma	0.3792 of 5 stars	$0.45 -2.2%	N/A	N/A	$7.34M	$70K	N/A	2	Upcoming Earnings
PMNT Perfect Moment	2.2728 of 5 stars	$0.28 +4.9%	$1.50 +441.5%	N/A	$12.98M	$22.93M	N/A	31
EVKG Ever-Glory International Group	N/A	$0.00 flat	N/A	N/A	$3K	N/A	N/A	4,300
ONON ON	4.8068 of 5 stars	$35.29 -0.4%	$58.40 +65.5%	N/A	$22.52B	$3.01B	49.01	3,963	Upcoming Earnings
AS Amer Sports	4.2856 of 5 stars	$34.60 -0.6%	$47.12 +36.2%	N/A	$19.16B	$6.57B	46.13	15,400

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SILO) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Silo Pharma (SILO) Competitors

SILO vs. PMNT, EVKG, ONON, AS, and LULU

How does Silo Pharma compare to Perfect Moment?

Summary

How does Silo Pharma compare to Ever-Glory International Group?

Summary

How does Silo Pharma compare to ON?

Summary

How does Silo Pharma compare to Amer Sports?

Summary

How does Silo Pharma compare to lululemon athletica?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SILO vs. The Competition

Silo Pharma Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Silo Pharma (SILO) Competitors

SILO vs. PMNT, EVKG, ONON, AS, and LULU

How does Silo Pharma compare to Perfect Moment?

Summary

How does Silo Pharma compare to Ever-Glory International Group?

Summary

How does Silo Pharma compare to ON?

Summary

How does Silo Pharma compare to Amer Sports?

Summary

How does Silo Pharma compare to lululemon athletica?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SILO vs. The Competition

Silo Pharma Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools